FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates
- September 25th, 2023
- 624 views
Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment, FemaSeed. This innovative solution is designed to deliver sperm directly to the fallopian tube, targeting the site of conception in women.
$FEMY was trading at $0.97 in the extended session, up $0.63 (+192.52%)
In other news, THOR Industries, Inc. (NYSE: THO), a leading recreational vehicle manufacturer, reported fourth-quarter fiscal 2023 earnings of $1.68 per share, surpassing the consensus EPS estimate of $0.96. The company's quarterly sales reached $2.74 billion, beating analysts' revenue projection of $2.42 billion.
Additionally, THOR Industries has provided guidance for full-year fiscal 2024, with expected diluted EPS in the range of $6.25 to $7.25, compared to the consensus EPS estimate of $7.12 for the period.
$THO was trading at $93.66 in after-hours, down $1.16 (-1.22%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login